Biaryl moieties, especially in the context of natural products (NPs), constitute a privileged scaffold for drug design. However, compound modifications that follow the installation of the defining C−C biaryl axis have not been well documented. Here, we report two iterative monooxygenases, JuiN and JuiO, that catalyze tandem and symmetric hydroxylation and epoxidation chemistries following C−C axis formation en route to the NP julichrome Q 6-6 . The crystal structure of JuiN-FAD-Q 6-6 and mutagenesis experiments revealed the substrate recognition mechanisms driving iterative hydroxylations along the C−C axis. The key to these studies was that the unstable intermediate julichrome Q 8-8 was successfully captured using an adsorptive resin in fermentations of a ΔjuiO mutant, thus invoking JuiO in the overall sequence of transformations. A Streptomyces griseorubiginosusderived enzyme, SgJuiO, was investigated in vitro as a substitute for insoluble JuiO. The biochemical reactions unambiguously demonstrated that SgJuiO iteratively catalyzes the complex sequence of epoxidations on both sides of the C−C biaryl linkage. These findings showcase a tailoring paradigm for biaryl NP biosynthesis and engineering.